We are creating some awesome events for you. Kindly bear with us.

New hi-tech lab set up in Hong Kong

Image Credits: HKSAR Government, Press Release

According to a recent press release, a precision cancer treatment solution provider opened its Next Generation Sequencing (NGS) laboratory in Hong Kong on 4 July 2019.

This is part of its strategic plan to meet the growing demand for cancer genomic profiling services in the Guangdong-Hong Kong-Macao Greater Bay Area.

The new laboratory is located at the Hong Kong Science Park. Measuring about 7,000 square feet, the laboratory is supported by a workforce responsible for sales, medical science and research and laboratory work, and is equipped with dual sequencing platforms (Ion GeneStudio S5 System and NextSeq 550 System) that boast both speed (quick turnover time for clinical reports) and throughput (high specimen volume or high sequencing depth for research purposes).

The lab has been designed and built to serve the clinical, pharmaceutical and research communities in the city and Asia, and also aspires to capture the tremendous opportunities in the Greater Bay Area in future.

Founded in Taiwan in 2014, cancer treatment solution company provides cancer patients with personalised genomic information based-treatment plans through its cutting-edge NGS platform, medical reports and integrated services. The platform is capable of detecting multiple genomic alterations using a single tissue sample within a single test run.

When used together with sophisticated bioinformatics analysis tools, curated proprietary medical informatic databases and data visualisation technologies, it can match identified mutations with not only approved therapies but also targeted therapies in clinical trials, thereby facilitating “precision medicine” treatment.

At the ceremony, the Chief Executive Officer of the company stated that with over 31,000 new cancer cases in Hong Kong every year, it is crucial for cancer treatment solutions to stay on the cutting edge, which is the mission of ACT Genomics.

The firm’s head stated that the company aim to transform the existing cancer treatment model and make cancer more manageable. Its NGS platform provides physicians with an essential reference for prescribing the most appropriate and effective treatment to a patient.

The company intends to draw from successful experiences in Taiwan and replicate it in Hong Kong with the help of this new world-class NGS laboratory.

The Associate Director-General of Investment Promotion stated that biotechnology is one of several innovation areas that is growing rapidly in Hong Kong. The Greater Bay Area is a huge market with a population of 71 million people. As the city is being positioned as the global innovation and technology hub within the Greater Bay Area and with our established business and legal systems, Hong Kong offers a convenient platform for international biotech and other laboratories to manage their operations across the Greater Bay Area.

The firm has been an innovation-driven cancer solution provider in Asia with offices in Hong Kong, Taiwan, Singapore and Japan.

It’s NGS technology and experienced bioinformatics team, it provides optimal cancer treatment planning, cancer relapse and drug resistance monitoring, cancer risk assessment and immunotherapy evaluation to medical professionals.

The firm’s team consists of medical professionals who specialise in biomarker identification, underlying disease mechanism discovery and genetic alteration exploration.

Pharmaceutical communities also benefit from its expertise in identifying targets for drug development, stratifying patients for clinical studies and delineating drug responses.

Hence, the presence of such a lab in Hong Kong is a boon on many fronts.


CTC Global Singapore, a premier end-to-end IT solutions provider, is a fully owned subsidiary of ITOCHU Techno-Solutions Corporation (CTC) and ITOCHU Corporation.

Since 1972, CTC has established itself as one of the country’s top IT solutions providers. With 50 years of experience, headed by an experienced management team and staffed by over 200 qualified IT professionals, we support organizations with integrated IT solutions expertise in Autonomous IT, Cyber Security, Digital Transformation, Enterprise Cloud Infrastructure, Workplace Modernization and Professional Services.

Well-known for our strengths in system integration and consultation, CTC Global proves to be the preferred IT outsourcing destination for organizations all over Singapore today.


Planview has one mission: to build the future of connected work. Our solutions enable organizations to connect the business from ideas to impact, empowering companies to accelerate the achievement of what matters most. Planview’s full spectrum of Portfolio Management and Work Management solutions creates an organizational focus on the strategic outcomes that matter and empowers teams to deliver their best work, no matter how they work. The comprehensive Planview platform and enterprise success model enables customers to deliver innovative, competitive products, services, and customer experiences. Headquartered in Austin, Texas, with locations around the world, Planview has more than 1,300 employees supporting 4,500 customers and 2.6 million users worldwide. For more information, visit www.planview.com.


SIRIM is a premier industrial research and technology organisation in Malaysia, wholly-owned by the Minister​ of Finance Incorporated. With over forty years of experience and expertise, SIRIM is mandated as the machinery for research and technology development, and the national champion of quality. SIRIM has always played a major role in the development of the country’s private sector. By tapping into our expertise and knowledge base, we focus on developing new technologies and improvements in the manufacturing, technology and services sectors. We nurture Small Medium Enterprises (SME) growth with solutions for technology penetration and upgrading, making it an ideal technology partner for SMEs.


HashiCorp provides infrastructure automation software for multi-cloud environments, enabling enterprises to unlock a common cloud operating model to provision, secure, connect, and run any application on any infrastructure. HashiCorp tools allow organizations to deliver applications faster by helping enterprises transition from manual processes and ITIL practices to self-service automation and DevOps practices. 


IBM is a leading global hybrid cloud and AI, and business services provider. We help clients in more than 175 countries capitalize on insights from their data, streamline business processes, reduce costs and gain the competitive edge in their industries. Nearly 3,000 government and corporate entities in critical infrastructure areas such as financial services, telecommunications and healthcare rely on IBM’s hybrid cloud platform and Red Hat OpenShift to affect their digital transformations quickly, efficiently and securely. IBM’s breakthrough innovations in AI, quantum computing, industry-specific cloud solutions and business services deliver open and flexible options to our clients. All of this is backed by IBM’s legendary commitment to trust, transparency, responsibility, inclusivity and service.

Send this to a friend